RecruitingNot applicableNCT06867809
Spine and Brain Stimulation for Movement Recovery After Cervical Spinal Cord Injury
Studying Spinal cord injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jason Carmel
- Principal Investigator
- Jason B. Carmel, MD, PhDColumbia University
- Intervention
- Epidural spinal cord stimulation and paired spine and brain stimulation(device)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2027
Study locations (2)
- NewYork-Presbyterian Hospital / Columbia University Irving Medical Center (NYPH/CUIMC), New York, New York, United States
- NewYork-Presbyterian Allen Hospital / Columbia University Irving Medical Center (NYPH/CUIMC), New York, New York, United States
Collaborators
National Institute of Neurological Disorders and Stroke (NINDS)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06867809 on ClinicalTrials.govOther trials for Spinal cord injury
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT06410001CE-STAND: Cervical Epidural STimulation After Neurologic DamageUniversity of Minnesota
- RECRUITINGNANCT07204184Multisite Transspinal Stimulation for Augmenting Recovery in Spinal Cord InjuryMaria Knikou, PT, MBA, PhD
- RECRUITINGNANCT06924177UTSW NORC Pilot Spinal Cord Injury Dietary ProgramUniversity of Texas Southwestern Medical Center
- ENROLLING BY INVITATIONNANCT06873776Arm and Leg Cycling for Accelerated SCI RecoveryShirley Ryan AbilityLab
- RECRUITINGNANCT07135583Non-Invasive Interventions for Respiratory Recovery in Chronic Spinal Cord InjuryThomas Jefferson University
- RECRUITINGNANCT07222033Self-balancing Personal Exoskeleton for SCI (WINY)Wandercraft
- RECRUITINGPHASE1, PHASE2NCT06677229Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord InjuryTechnophage, SA
- RECRUITINGPHASE1, PHASE2NCT06922890First-in-Human Clinical Trial of STUP-001, an In Vivo Direct Cell Conversion Gene Therapy for AIS-A/B Chronic Spinal Cord InjuryYonsei University